FDA Approves Merck's DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older - Business Wire
FDA Approves Merck's DIFICID® (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older Business Wire
Comments
Post a Comment